Heart failure and transplantation with Dr Ileana Piña

ACC HFpEF Guidance: What to Know Ileana Piña, MD, MPH, discusses the Expert Consensus Decision Pathway from ACC focused on the definition, diagnosis, and treatment of heart failure with preserved ejection fraction.
Experts And Viewpoints, May 18, 2023
Defining Heart Failure: EF Slicing and Dicing Ileana L. Piña, MD, MPH, discusses the definition of heart failure based on various ejection fraction ranges and changes.
Experts And Viewpoints, May 05, 2023
Clues to How SGLT2 Inhibitors Work: CAMEO-DAPA Ileana Piña, MD, MPH, and Barry A. Borlaug, MD, discuss the CAMEO-DAPA study in patients with HFpEF and potential mechanisms of action for SGLT2 inhibitors.
Experts And Viewpoints, April 20, 2023
STRONG-HF: This Is the Science, Let's Get It Done Ileana L. Piña, MD, MPH, discusses the need to implement the findings of STRONG-HF in heart failure clinics across the globe.
Experts And Viewpoints, April 03, 2023
A 'Game Changer' for Heart Transplant? Dr DeVore, from the first US center to perform an adult heart transplant using an organ donated after circulatory death, explains the differences and similarities with brain-dead donation to Dr Piña.
Experts And Viewpoints, March 24, 2023
AHA 2022 Is Finding and Fixing Iron Deficiency in HF Beneficial? Ileana Piña interviews Paul Kalra about the IRONMAN trial from the American Heart Association which randomized HF patients with iron deficiency to IV ferric derisomaltose repletion or no infusions.
Experts And Viewpoints, November 30, 2022
AHA 2022 STRONG-HF Strategy for Intense ADHF Discharge Care Explained Alexandre Mebazaa gives Ileana Piña the details on the STRONG-HF trial that showed benefits for early intensive drug therapy after hospitalization for acute decompensated heart failure.
Experts And Viewpoints, November 14, 2022
AHA 2022 Meds and Community Over Mindfulness for Most Hypertension Catch up on blood pressure presentations from the 2022 American Heart Association meeting, including ones on mindfulness, community approaches, and a comparison of hydrochlorothiazide and chlorthalidone.
Experts And Viewpoints, November 11, 2022
ESC 2022 DELIVERing the Details on Dapagliflozin in Heart Failure Drs Pina and Solomon discuss the DELIVER trial presented at the European Society of Cardiology and whether all patients with heart failure should get SGLT2 inhibitors regardless of ejection fraction.
Experts And Viewpoints, September 02, 2022
The Pig Heart Transplant Surgeon on What He Learned Ileana Piña speaks with Bart Griffith about the first porcine-to-human cardiac xenotransplantation and where the field is going.
Experts And Viewpoints, August 15, 2022
Key Points From the New Heart Failure Guidelines Dr Ileana Piña discusses the 2022 AHA/ACC/HFSA heart failure guidelines and how they compare with the European guidelines and recent data on heart failure.
Experts And Viewpoints, May 04, 2022
ACC 2022 SODIUM-HF Simplifies Message to Patients on Diet Drs Ileana Piña and Justin Ezekowitz discuss results from the SODIUM-HF trial, which investigated the effects of a pragmatic intervention to reduce dietary sodium intake in patients with heart failure.
Experts And Viewpoints, April 08, 2022
Is It Time to Redefine Iron Deficiency? Ileana Piña was intrigued by a paper questioning whether the definitions of iron deficiency used in HF trials and guidelines are the best ones.
Experts And Viewpoints, February 22, 2022
AHA 2021 CHIEF-HF: No-Touch Initiation of Canagliflozin Improves QoL Ileana Piña and Eldrin Lewis discuss a novel, all-virtual trial of the SGLT2 inhibitor canagliflozin in patients with heart failure.
Experts And Viewpoints, November 24, 2021
ESC 2021 Heart Failure Drug Management Tips and Tricks Drs Ileana Piña and Carolyn Lam discuss how they juggle all the drugs indicated for patients with heart failure.
Experts And Viewpoints, September 29, 2021
ESC 2021 AVANTI: Could a 'Vaptan' Replace Loop Diuretics in Acute HF? Ileana Piña and investigator James Udelson discuss the phase 2 AVANTI trial presented at ESC on a novel 'vaptan' drug.
Experts And Viewpoints, September 17, 2021
ESC 2021 Empagliflozin in HFpEF: Putting EMPEROR-Preserved in Context Javed Butler discusses the details of the trial on empagliflozin in HFpEF with Ileana Piña and what might be learned from the subgroup analyses.
Experts And Viewpoints, August 31, 2021
ESC-HFA 2021 Can We Agree on a Universal Definition of Heart Failure? Ileana Piña speaks with Professor Andrew Coats about the universal definition of heart failure and upcoming guidelines from the Heart Failure Association of the European Society of Cardiology.
Experts And Viewpoints, July 22, 2021
ACC 2021 REHAB-HF Lays Groundwork for Recovery of Function Post HF Ileana Pina speaks with Dalane Kitzman about a tailored strategy of physical rehabilitation to improve balance, strength, mobility, and endurance after acute HF.
Experts And Viewpoints, May 24, 2021
ACC 2021 Sacubitril/Valsartan: Trending Toward PARADISE Post MI? PARADISE-MI fell short on statistical significance but investigator Marc Pfeffer is persuaded by trends for clinical benefit. The key: 'Start the drug early and sustain it,' he tells Ileana Pina.
Experts And Viewpoints, May 19, 2021

No Results